Table 1.
Characteristics | All Patients, n = 56 | Non‐BAV, n = 26 | BAV, n = 30 | P Value |
---|---|---|---|---|
Age, y | 81.9 ± 5.9 | 81.6 ± 6.5 | 82.2 ± 5.4 | NS |
Female gender | 28 (50.0%) | 11 (42.3%) | 13 (43.3%) | NS |
Logistic Euroscore, % | 22.9 ± 11.1 | 24.6 ± 8.7 | 21.4 ± 12.1 | NS |
STS PROM, % | 6.0 ± 2.9 | 5.8 ± 2.7 | 6.2 ± 3.1 | NS |
BMI | 28.2 ± 4.7 | 28.6 ± 4.8 | 27.9 ± 4.6 | NS |
EF, % [IQR] | 60.0 [46.3–63.8] | 55.0 [35.0–60.0] | 60.0 [53.8–65.0] | 0.01 |
Pmean, mm Hg | 42.8 ± 17.8 | 36.0 ± 17.3 | 48.5 ± 17.7 | 0.01 |
AVA, cm2 | 0.7 ± 0.2 | 0.7 ± 0.2 | 0.6 ± 0.2 | NS |
GFR, mL/min | 61.4 ± 23.7 | 58.7 ± 19.3 | 63.8 ± 26.9 | NS |
NYHA class 3 and 4 | 51 (91.1%) | 23 (88.5%) | 28 (93.3%) | NS |
Hypertension | 54 (96.4%) | 25 (96.2%) | 29 (96.7%) | NS |
Diabetes | 23 (41.1%) | 10 (38.5%) | 13 (43.3%) | NS |
Hyperlipidemia | 28 (50.0%) | 10 (38.5%) | 18 (60.0%) | NS |
Prior stroke | 9 (16.1%) | 5 (19.2%) | 4 (13.3%) | NS |
Prior MI | 7 (12.5%) | 5 (19.2%) | 2 (6.7%) | NS |
Atrial fibrillation | 23 (41.1%) | 9 (34.6%) | 14 (46.7%) | NS |
CAD | 34 (60.7%) | 16 (61.5 %) | 18 (60.0%) | NS |
PVD | 11 (19.6%) | 8 (30.8%) | 3 (10.0%) | 0.09 |
CABG | 10 (17.9%) | 6 (23.1%) | 4 (13.3%) | NS |
COPD | 10 (17.9%) | 6 (23.1%) | 4 (13.3%) | NS |
Annulus | 24.3 ± 1.8 | 24.6 ± 1.9 | 24.2 ± 1.8 | NS |
Ag‐score [IQR] | 2523 [1564–3319] | 2464 [1480–3466] | 2531 [1645–3277] | NS |
Abbreviations: Ag‐score, calcium score of the aortic valve; Annulus, effective systolic annulus diameter measured by multislice computed tomography; AVA, aortic valve area; BAV, balloon valvuloplasty; BMI, body mass index; CABG, coronary artery bypass graft; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; EF, ejection fraction; GFR, glomerular filtration rate; IQR, interquartile range; MI, myocardial infarction; NS, not significant; NYHA, New York Heart Association; Pmean, mean transvalvular gradient; PVD, peripheral vascular disease; STS PROM, Society of Thoracic Surgeons Score for Prediction of Mortality.